Peraso (NASDAQ: PRSO) Solving the Drone Bottleneck: It’s Not the Flight It’s the SignalAs the global drone, AI infrastructure, and autonomous systems markets accelerate, the industry's next major challenge is shifting from keeping drones in the air to keeping them securely connected. While manufacturers continue improving flight time, payload capacity, and onboard AI, the real bottleneck is increasingly becoming wireless signal communications —the ability to move massive amounts of mission-critical data securely, reliably, and in real time across increasingly crowded and contested environments.
Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving EquipmentEvery FLYTE aircraft combines the Cirrus Vision Jet’s CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment.
Catheter Precision, Inc. Announces Issuance of Two Key PatentsNew Intellectual Property Covers VIVO Technology and Cardionomix Heart Failure Technology
Flyte Announces Successful Launch of New Direct-to-Consumer Booking PlatformRevenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) as Customer Adoption Accelerates Across Key Travel Markets
Peraso (NASDAQ: PRSO) Could Be One of the Most Overlooked AI Infrastructure and Military Drone Stocks Under $1 – More Stocks InsideWhile much of Wall Street's attention remains focused on artificial intelligence giants and multi-billion-dollar semiconductor companies, Peraso Inc. (
NASDAQ: PRSO) continues to quietly build a position in several of the fastest-growing technology markets, including military drones, AI infrastructure, autonomous systems, secure communications, robotics, and electronic warfare .
IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug DiscoveryIGC Pharma, Inc. (
NYSE: IGC) a clinical-stage Biotechnology company developing treatments for Alzheimer's Disease and Artificial Intelligence (AI) enabled healthcare technologies, today announced the beta release of its proprietary Agentic Harmonization Assistant ("AHA"), a patent-pending Healthcare AI platform designed to accelerate Alzheimer's Drug Discovery, Clinical Research , Precision Medicine , and Pharmaceutical Development by helping researchers quickly combine and organize Alzheimer's disease , aging-related, and other medical data that is often scattered across multiple databases, studies, hospitals, clinical trials, healthcare systems, and research institutions.
Flyte Partners with GSE Worldwide and PGA TOUR Professional Emiliano Grillo, Debuted at the 2026 U.S. OpenPartnership positions Flyte within elite professional sports ecosystem through leading talent agency GSE Worldwide
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORMFlyte to expand private aviation demand, increase aircraft utilization, and accelerate revenue growth
Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 TournamentCompany Positions Platform to Capture High-Value Regional Travel Demand and Build Brand Exposure during Largest Global Sporting Event
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies
FLYTE ACTIVATES HIGH-FREQUENCY BELMONT STAKES FLIGHT PROGRAM, DEPLOYING FLEET TO CAPTURE TRIPLE CROWN DEMANDFlyte’s regional mobilization aims to capitalize on one of the most lucrative single-weekend surges in elite sports tourism
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITIONMedical Device Momentum Accelerates Globally While Flyte Establishes High-Growth Aviation Platform with Immediate Revenue Traction
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air TravelPremium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer DemandPositioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha’s Vineyard
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth StrategyUSPTO Validates Catheter Precision’s LockeT Technology with Key Patent Allowance, Reinforcing Competitive Dominance, Long-Term Value Creation and Strengthening Barriers to Entry
FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTESMajor Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder ApprovalTransaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth
Catheter Precision Announces Accepted Publication in Leading European Medical JournalClinical Evidence Further Demonstrates Efficacy and Accuracy of VIVO for Ventricular Procedures
New LockeT Data Accepted in Leading Electrophysiology JournalFORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention Device for Large-Bore Venous Access Closure” has been accepted by the Journal of Interventional Cardiac Electrophysiology (JICE), a leading medical journal in the field of electrophysiology.
Catheter Precision Engages Strategic AdvisorGoal to unlock value in cardiac electrophysiology assets Strategic process to include outreach to leading global medical device companies
Flyte Hops: Vision Jet Platform Seeks to Redefine Private AviationHops Scalable Vision Jet Fleet Expansion Unlocking High-Frequency Short-Haul Regional Travel
